Taylor Dennison is a pharmacist who is specialized in Oncology in Chapel Hill, North Carolina. Patients can reach her at 101 Manning Dr, Chapel Hill or contact her on 984-974-0000. Active license number of Taylor Dennison is S025258 for Oncology in North Carolina. Taylor Dennison is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Taylor Dennison speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Taylor Dennison
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
101 Manning Dr, Chapel Hill, North Carolina, 27514-4220
Phone:
984-974-0000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Taylor Dennison are as mentioned below.
NPI Number:
1669155818
NPI Enumeration Date:
14 Aug, 2023
NPI Last Update On:
14 Aug, 2023
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Taylor Dennison are as mentioned below.
Specialization
License Number
State
Status
Oncology
S025258
North Carolina
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4922 N 74th St, Scottsdale, Arizona
Zip:
85251-1308
Phone Number:
513-545-7495
Fax Number:
--
Patients can reach Taylor Dennison at 101 Manning Dr, Chapel Hill, North Carolina or can call on phone at 984-974-0000.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.